REGINA SUDDUTH: Open Payments
NPI 1265175186 · SYLACAUGA, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,137 in 101 payments from 14 companies in 2025. Trend: 2023 $81 · 2024 $2,209 · 2025 $2,137
Food & beverage: $2,103Education: $34
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 43 | $680 |
| AstraZeneca Pharmaceuticals LP | 13 | $518 |
| GENZYME CORPORATION | 10 | $166 |
| Amgen Inc. | 10 | $165 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $149 |
| Regeneron Healthcare Solutions, Inc. | 6 | $146 |
| INTUITIVE SURGICAL, INC. | 1 | $93 |
| Insmed, Inc. | 2 | $59 |
| Novartis Pharmaceuticals Corporation | 2 | $42 |
| Viatris Specialty LLC | 2 | $41 |
Products named: TRELEGY ELLIPTA, AIRSUPRA, DUPIXENT, TEZSPIRE, NUCALA, GLASSIA, Da Vinci Surgical System, XOLAIR.
Industry payments across AL — which companies pay providers there.
